In order to effectively play the government’s role as a bridge, relieve enterprises from difficulties, and help private enterprises embark on the path of high-quality development, on January 17, Yu Yanfei, Director of the Industrial Division of Wuhan National Bioindustry Base Construction Service Center, and his delegation came to our company for investigation and guidance. Qiu Xuewen, general manager of Wuhan Half the Sky, and relevant personnel participated in the symposium.
At the meeting, Qiu Xuewen, general manager of Wuhan Half the Sky, expressed a warm welcome to the arrival of Director Yu Yanfei and his delegation, and introduced in detail the company’s business development status in 2023 and its overall future development plan. He said that the development of Wuhan Half the Sky is inseparable from the care and support of leaders at all levels in Wuhan East Lake High-tech Zone. The company will achieve remarkable results in product research and development, market expansion, external cooperation and other aspects in 2023. The company currently has 9 national Class III medical device registration certificates, including the country’s first registration certificate for the radio frequency ultrasound dual-output surgical system that coagulates 7mm blood vessels. This is a major breakthrough for Half the Sky in the field of ultrasonic scalpel technology.
General Manager Qiu Xuewen emphasized that products are the core of enterprise development. In 2024, Wuhan Half the Sky will strengthen the construction of its marketing team and production automation, and continue to increase investment in R&D and innovation to create more high-precision products that lead the trend of minimally invasive surgery. Wuhan Half the Sky is committed to building a Chinese energy minimally invasive surgery platform and accelerating the substitution of domestically produced high-end medical devices.
Director Yu Yanfei spoke highly of the achievements achieved by Half the Sky. She said that Wuhan Half the Sky, as a local medical device company, has more than 20 years of technical experience in radio frequency and ultrasound technology. She hopes that Wuhan Half the Sky can continue to leverage its advantages, continuously improve its core competitiveness, and make greater contributions to achieving high-quality development.
At the meeting, Director Yu Yanfei learned in detail about the problems encountered by Half the Sky in its business development and gave targeted and valuable suggestions. She said that the Office of Biology fully supports Wuhan Half the Sky’s implementation of domestic substitution in the field of high-end medical devices, and is willing to do its best to provide channel and resource assistance. She hopes that both parties can strengthen communication in the future and jointly promote the high-quality development of Hubei’s medical industry.
Wuhan Half the Sky General Manager Qiu Xuewen once again expressed his gratitude to Director Yu Yanfei for his help and guidance, and shared Wuhan Half the Sky’s three major dreams: first, to provide 30 specialties with leading products and comprehensive solutions from prevention, diagnosis, treatment, rehabilitation to nursing technology; second, to build a large-scale intelligent production factory for medical device products; third, to build 10 chain specialty hospitals.
This survey is of great significance for Wuhan Half the Sky to clarify the development direction and accelerate the pace of development. In the future, Wuhan Half the Sky will adhere to the corporate mission of “healthy half the sky and benefit all mankind”, continue to delve into the field of minimally invasive medical devices, continuously improve and polish the quality and service quality, firmly follow the path of sustainable and high-quality development, and contribute to the realization of domestic substitution of high-end medical devices!
